Literature DB >> 2420723

Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

A Nicole, O Spertini, D Lavanchy, P C Frei.   

Abstract

Eight patients, convalescent from acute hepatitis, all negative for HBsAg, anti-HBc, anti-HA-IgM, anti-CMV and anti-EB, and all positive for non-A, non-B related antigen and/or antibody in at least one sample during the course of disease, were investigated. Their specific cell-mediated immunity was tested using the leukocyte migration inhibition test in presence of a previously described non-A, non-B related antigen. A control group consisted of ten individuals (two normal subjects, six patients recovering from acute hepatitis B and two with autoimmune chronic active hepatitis). Leukocyte migration was inhibited by the antigen in seven of the eight patients. The test was negative in all control subjects. It is thus demonstrated that after recovery, patients with non-A, non-B viral hepatitis develop a cellular immune response specific for purified non-A, non-B related antigen. The association between the described antigen and viral hepatitis non-A, non-B can now be established not only by immunoprecipitation, but also by a cellular test.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420723     DOI: 10.1007/bf01644803

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  31 in total

1.  Lack of leukocyte migration inhibition by hepatitis B antigen and normal nonspecific immunoreactivity in asymptomatic carriers.

Authors:  M Desaules; P C Frei; J Libanska; B Wuilleret
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

2.  Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.

Authors:  P Erard
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

3.  Chronic non-A, non-B hepatitis carrier state: transmissible agent documented in one patient over a six-year period.

Authors:  E Tabor; L B Seeff; R J Gerety
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

4.  Non-A, maybe-B hepatitis.

Authors:  S M Feinstone; J H Hoofnagle
Journal:  N Engl J Med       Date:  1984-07-19       Impact factor: 91.245

5.  Detection of virus-associated antigen in serum and liver of patients with non-A non-B hepatitis.

Authors:  L Vitvitski; C Trepo; A M Prince; B Brotman
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

6.  Detection of an antigen-antibody system in serum associated with human non-A, non-B hepatitis.

Authors:  E Tabor; F D Mitchell; A M Goudeau; R J Gerety
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

7.  Demonstration of a single antigen-antibody system in 26 patients with non-A, non-B viral hepatitis.

Authors:  O Spertini; P C Frei
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

8.  Post-transfusion hepatitis: antigen/antibody systems correlated with non-A, non-B hepatitis.

Authors:  L V Chircu; M Pezzella; V Lacava; G Ricci
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

9.  Transmission of non-A, non-B hepatitis from man to chimpanzee.

Authors:  E Tabor; R J Gerety; J A Drucker; L B Seeff; J H Hoofnagle; D R Jackson; M April; L F Barker; G Pineda-Tamondong
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

10.  An antigen detected frequently in human sera with elevated levels of alanine aminotransferase: a potential marker for non-A, non-B hepatitis.

Authors:  A R Neurath; C E Stevens; N Strick; W Szmuness; W R Oleszko; E J Harley
Journal:  J Gen Virol       Date:  1980-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.